The short version
35 companies supply this market — deep enough that no single failure threatens the supply.
Market view
paclitaxel
70 marketed package NDCs · 35 active manufacturers
Most dispensed: 6 mg/mL · Injection, Solution · #1 vial, multi-dose/carton / 50 ml in 1 vial, multi-dose · 6 mg/mL · Injection, Solution · #1 vial, multi-dose/carton / 16.7 ml in 1 vial, multi-dose · 6 mg/mL · Injection, Solution · #1 vial, multi-dose/carton / 5 ml in 1 vial, multi-dose · 100 mg/20mL · Injection, Powder, Lyophilized, For Suspension · #1 vial, single-use/carton / 20 ml in 1 vial, single-use
What changed in the last 90 days
Every detected change for paclitaxel, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- PaclitaxelAug 7, 2026Mfr enteredSeripharm S.A.S. · paclitaxel
- PaclitaxelAug 7, 2026New productSeripharm S.A.S.
Same drug class
Other molecules FDA puts in Microtubule Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Paclitaxel in shortage right now?
- No. FDA does not currently list Paclitaxel in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Paclitaxel?
- 35 companies have marketed Paclitaxel in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.